Thermo Fisher Scientific Inc. reported consolidated earnings results for the fourth quarter and full year ended December 31, 2017. Revenue for the quarter grew 22% to $6.05 billion in 2017, against $4.95 billion in 2016. Organic revenue growth was 8%; acquisitions increased revenue by 11% and currency translation increased revenue by 3%. GAAP diluted EPS in the fourth quarter decreased to $1.30, against $1.59 in the same quarter last year, due to the one-time tax provision previously noted. GAAP operating income for the fourth quarter of 2017 grew to $0.96 billion, compared with $0.75 billion in the fourth quarter of 2016. Adjusted EPS in the fourth quarter of 2017 increased 16% to $2.79, against $2.41 in the fourth quarter of 2016. Adjusted operating income for the fourth quarter of 2017 grew 18% compared with the year-ago quarter. Income before income taxes was $820 million against $652 million a year ago. Income from continuing operations was $530 million against $633 million a year ago. Net income was $528 million against $630 million a year ago. Adjusted operating income was $1,450 million against $1,227 million a year ago. Adjusted net income was $1,128 million against $956 million a year ago. GAAP net cash provided by operating activities was $1,866 million against $1,205 million a year ago. Purchases of property, plant and equipment was $215 million against $133 million a year ago. Revenue for the full year grew 14% to $20.92 billion in 2017, against $18.27 billion in 2016. Organic revenue growth was 5%; acquisitions increased revenue by 9% and currency translation increased revenue slightly. GAAP diluted EPS for the full year increased to $5.59, against $5.09 in 2016. GAAP diluted EPS in 2017 reflects the one-time tax provision. GAAP operating income for 2017 grew to $2.97 billion, compared with $2.45 billion a year ago. Adjusted EPS for the full year rose 15% to $9.49, against $8.27 in 2016. Adjusted operating income for 2017 grew 15% compared with 2016, and adjusted operating margin expanded 10 basis points to 23.2%, compared with 23.1% a year ago. Income before income taxes was $2,429 million against $2,024 million a year ago. Income from continuing operations was $2,228 million against $2,025 million a year ago. Net income was $2,225 million against $2,022 million a year ago. Adjusted operating income was $4,860 million against $4,222 million a year ago. Adjusted net income was $3,775 million against $3,288 million a year ago. GAAP net cash provided by operating activities was $4,005 million against $3,258 million a year ago. Purchases of property, plant and equipment was $508 million against $444 million a year ago.